One of the first commercial applications of cell programming that have launched off our platform is the ability to program brewing yeast so that they produce valuable ingredients during fermentation, essentially “brewing” new ingredients in a process that looks like brewing beer. These cultured ingredients can offer a more accessible and sustainable way to produce a wide array of important products, from fragrances to pharmaceuticals. Our partnership with Cronos Group, an innovative global cannabinoid company, is helping them produce a range of rare and often otherwise inaccessible cannabinoid molecules using this process.
I’m thrilled to share that Cronos is beginning their commercial production of the first such rare cultured cannabinoid product we are enabling for them, CBG. Given the progress of the program already achieved, we are amending our agreement in order to accelerate commercialization, which we hope will facilitate these products being first to market in Canada.